Literature DB >> 36010914

Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.

Fang Bao1,2,3, Jiayue Liu1,2, Haiyang Chen1,2, Lu Miao3, Zhaochao Xu3, Guixin Zhang1,2.   

Abstract

Cholangiocarcinoma (CCA) is a multifactorial malignant tumor of the biliary tract, and the incidence of CCA is increasing in recent years. At present, the diagnosis of CCA mainly depends on imaging and invasive examination, with limited specificity and sensitivity and late detection. The early diagnosis of CCA always faces the dilemma of lacking specific diagnostic biomarkers. Non-invasive methods to assess the degree of CAA have been developed throughout the last decades. Among the many specimens looking for CCA biomarkers, bile has gotten a lot of attention lately. This paper mainly summarizes the recent developments in the current research on the diagnostic biomarkers for CCA in human bile at the levels of the gene, protein, metabolite, extracellular vesicles and volatile organic compounds.

Entities:  

Keywords:  bile; biomarker; cholangiocarcinoma; diagnosis

Year:  2022        PMID: 36010914      PMCID: PMC9406189          DOI: 10.3390/cancers14163921

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.575


  176 in total

1.  Identification and validation of specific methylation profile in bile for differential diagnosis of malignant biliary stricture.

Authors:  Ye Zhang; Bin Yang; Zhi Du; Ying-Tang Gao; Yi-Jun Wang; Xiang Jing; Tong Bai
Journal:  Clin Biochem       Date:  2010-08-18       Impact factor: 3.281

2.  Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.

Authors:  Abigail A Zabron; Verena M Horneffer-van der Sluis; Christopher A Wadsworth; Fiona Laird; Magdalena Gierula; Andrew V Thillainayagam; Panagiotis Vlavianos; David Westaby; Simon D Taylor-Robinson; Robert J Edwards; Shahid A Khan
Journal:  Am J Gastroenterol       Date:  2011-06-14       Impact factor: 10.864

Review 3.  Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers.

Authors:  Catherine Guette; Isabelle Valo; Alexandra Vétillard; Olivier Coqueret
Journal:  Proteomics Clin Appl       Date:  2014-12-28       Impact factor: 3.494

4.  Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses.

Authors:  Valeria Severino; Jean-Marc Dumonceau; Myriam Delhaye; Solange Moll; Isabelle Annessi-Ramseyer; Xavier Robin; Jean-Louis Frossard; Annarita Farina
Journal:  Gastroenterology       Date:  2017-05-04       Impact factor: 22.682

5.  Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.

Authors:  Ander Arbelaiz; Mikel Azkargorta; Marcin Krawczyk; Alvaro Santos-Laso; Ainhoa Lapitz; Maria J Perugorria; Oihane Erice; Esperanza Gonzalez; Raul Jimenez-Agüero; Adelaida Lacasta; Cesar Ibarra; Alberto Sanchez-Campos; Juan P Jimeno; Frank Lammert; Piotr Milkiewicz; Marco Marzioni; Rocio I R Macias; Jose J G Marin; Tushar Patel; Gregory J Gores; Ibon Martinez; Félix Elortza; Juan M Falcon-Perez; Luis Bujanda; Jesus M Banales
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

6.  Bile Processing Protocol for Improved Proteomic Analysis.

Authors:  Sergio Ciordia; Gloria Alvarez-Sola; María Rullán; Jesús M Urman; Matías A Ávila; Fernando J Corrales
Journal:  Methods Mol Biol       Date:  2022

Review 7.  The metabolomic window into hepatobiliary disease.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  J Hepatol       Date:  2013-05-25       Impact factor: 25.083

Review 8.  MicroRNAs in cancer: small molecules with a huge impact.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

9.  Regulation of S100A8/A9 (calprotectin) binding to tumor cells by zinc ion and its implication for apoptosis-inducing activity.

Authors:  Yuichi Nakatani; Masatoshi Yamazaki; Walter J Chazin; Satoru Yui
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

10.  Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures.

Authors:  Aatur D Singhi; Marina N Nikiforova; Jennifer Chennat; Georgios I Papachristou; Asif Khalid; Mordechai Rabinovitz; Rohit Das; Savreet Sarkaria; M Samir Ayasso; Abigail I Wald; Sara E Monaco; Michael Nalesnik; N Paul Ohori; David Geller; Allan Tsung; Amer H Zureikat; Herbert Zeh; J Wallis Marsh; Melissa Hogg; Kenneth Lee; David L Bartlett; James F Pingpank; Abhinav Humar; Nathan Bahary; Anil K Dasyam; Randall Brand; Kenneth E Fasanella; Kevin McGrath; Adam Slivka
Journal:  Gut       Date:  2019-04-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.